FDA Authorizes Second Booster Dose of Pfizer-BioNTech and Moderna COVID-19 Vaccines for Older and Immunocompromised Individuals

Published: 03/30/2022

  • Food and Drug Administration,
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

The U.S. Food and Drug Administration authorized and the CDC has recommended a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for sev

Sign Up for Free Trial